Buy or sell guide

A fast read on Wall Street conviction, live analyst commentary on X, and current valuation context for Morgan Stanley.
Updated 2026-06-21
Wall Street currently rates MS buy with a 12-month price target of $201 (-9.8% downside). The sections below cover the bull case, key risks, and latest earnings context for MS.
Wall Street verdict
52 analysts currently cover MS. Below is their consensus rating, price target range, and implied upside.
According to 52 analysts, Morgan Stanley (MS) is rated Buy with a consensus 12-month price target of $201 — representing 10% downside from today's price of $223. The bull case target is $211, the bear case is $187.
At $223.17, the consensus setup implies -9.8% versus the 12-month target.
Below, compare that institutional answer with the live analyst commentary on X for MS right now.
Analyst ratings update weekly. Get MS's next verdict in your inbox.
Free. No account needed. Unsubscribe any time.
Live commentary on X
Real posts from high-reach stock analysts mentioning MS, shown exactly as written. Sorted by engagement — most discussed first.
No recent posts captured
No high-reach analysts have posted about MS in the last 7 days. Check back after the next earnings release or market-moving event.
Should you buy MS?
A structured look at the bull case, the risks, and the most recent earnings execution for MS before you decide whether to buy, hold, or sell.
MS beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.
What keeps the long thesis intact
Wall Street rates MS buy, giving the bull case institutional backing from 52 analysts.
What can break the setup quickly
Watch whether new negative commentary on MS points to these structural risks or is simply reacting to short-term price moves.
Last Quarter
Deep dive into MS consensus models and risk factors.
Wall Street verdict, signals, and target summaries.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MS stock.
MS faces headwinds — analysts' $201 target is -9.8% from $223.17, suggesting limited near-term upside. This is informational only — verify the data and consider your own risk tolerance before deciding.
Timing depends on your horizon, but the data signals are: consensus rating "Buy" with -9.8% upside to the $201 target. In the past 30 days, 1 of 1 covering analysts raised their price targets — a bullish signal.
MS's consensus 12-month price target is $201, set by 52 Wall Street analysts. The bull case high is $211 and the bear case low is $187. From the current price of $223.17, this implies -9.8% upside.
MS appears overvalued — the $201 consensus target is -9.8% from today's $223.17. It trades at a forward P/E of 18.8x. Targets range from $187 (bear) to $211 (bull), reflecting different assumptions about growth and margins.
MS reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $201 target. Consider position sizing rather than going all-in pre-print.
Of 52 analysts covering Morgan Stanley (MS): 0 Strong Buy, 28 Buy, 24 Hold, 0 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $201 (range $187–$211). Bullish analysts outnumber bearish by more than 2-to-1.
No analyst currently rates MS a Sell, but the 24 Hold ratings reflect concerns about valuation, execution risk, or near-term catalysts. See the Bull vs. Risk cards above for the specific theses on Morgan Stanley.
This page is for informational purposes only and does not constitute financial advice. Always conduct your own research before investing.